Home > Journals > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Past Issues > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2011 August;170(4) > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2011 August;170(4):259-62

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE

A Journal on Internal Medicine and Pharmacology


Indexed/Abstracted in: BIOSIS Previews, EMBASE, Scopus, Emerging Sources Citation Index

 

REVIEWS  


Gazzetta Medica Italiana Archivio per le Scienze Mediche 2011 August;170(4):259-62

language: Italian

Aliskiren and renin-angiotension system inhibition

Incardona V. M., Dato E., Dato A. G.

Centro di Diagnostica Cardiovascolare del Dott. Dato Achille Giuseppe & C. Sas, Paternò, Catania, Italia


PDF  


The renin-angiotension system inhibition is a very efficacious pharmacological approach in control of cardiovascular and renal diseases. Aliskiren is a direct inhibitor of rennin and clinical trials prove a good control of blood pressure and protective effect in cardiovascular and renal diseases. After the promising results obtained, future clinical trials asses and confirm the organ-protective effects of aliskiren in the vascular diseases.

top of page

Publication History

Cite this article as

Corresponding author e-mail